tradingkey.logo

Tenaya Therapeutics slides after launching stock offering

ReutersDec 11, 2025 10:25 PM

Drug developer Tenaya Therapeutics' TNYA.O shares slide 12.5% to $1.19 in extended trading

TNYA unveils public offering of common stock and warrants; size not disclosed

Leerink Partners and Piper Sandler are joint bookrunning managers for offering

Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition

TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data

All eight brokerages covering the stock rate it "buy" or higher; median PT $5 - data compiled by LSEG

As of last close, TNYA stock down 4.9% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI